Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive perspective. Proponents often stress the possibility for significant therapeutic gains, principally in conditions where conventional therapies have proven ineffective. However, this is to evaluate the significant financial burden associated with CPI stem cell thera